Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Netherlands J Med 2007;65(11):411--18
Abdulmalik, S., Gallo, J., Nip, J., Katebifar, S., Arul, M., Lebaschi, A., et al
Even with commercial insurance, patients often face high deductibles and prior authorization delays that can take weeks
Laboratory review: The rationale for banning hCG and estrogen-pathway markers blockers [PMID: 16478815] Laboratory literature summary: laboratory review: The rationale for banning hCG and estrogen-pathway markers-pathway markers blockers in sport
US$ 22.64
US$ 27.78
US$ 20.18
US$ 26.86
US$ 23.70
US$ 24.29
US$ 27.42
US$ 24.06
US$ 26.04
US$ 25.61
US$ 24.80
US$ 28.33
US$ 20.93
US$ 23.87
US$ 21.29
US$ 24.37
